.
MergerLinks Header Logo

New Deal


Announced

Completed

TPG and ADIA-backed UPL completed the acquisition of Arysta LifeScience from Platform Specialty Products for $4.2bn.

Financials

Edit Data
Transaction Value£3,224m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA9.9x
Share Price Premium-
One Off Charge-

Synopsis

Edit

TPG and ADIA-backed UPL acquired Agricultural Solutions business of Platform Specialty Products, a global specialty chemicals company, which consists of Arysta LifeScience and its subsidiaries for $4.2bn in cash. The Company also successfully paid off its existing credit facility, including its existing senior secured term loans and revolving credit facility, and intends to complete the redemption of its 6.% and 6.5% senior notes on February 1st, 2019. This transaction represents the achievement of Platform’s objective of separating its Agricultural Solutions and Performance Solutions businesses, while establishing a pre-eminent global off-patent crop protection business. "Arysta grew and matured immensely during our period of ownership through acquisitions, integrations and investment. This is a terrific company with robust global sales and innovation capabilities, proven products, and world-class talent. We are thankful for what Arysta accomplished during its time as a part of Platform and for the efforts of its team around the world.” Rakesh Sachdev, Platform Chief Executive Officer.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US